• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓性血小板减少性紫癜、肝素诱导的血小板减少症和弥散性血管内凝血。

Thrombotic Thrombocytopenic Purpura, Heparin-Induced Thrombocytopenia, and Disseminated Intravascular Coagulation.

机构信息

Division of Pediatric Hematology Oncology, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, 4401 Penn Avenue, Suite 501A, Pittsburgh, PA 15224, USA.

Division of Hematology Oncology, Department of Medicine, Clinical Apheresis and Blood Services, Vitalant Northeast Division, University of Pittsburgh School of Medicine, 3636 Boulevard of the Allies, Pittsburgh, PA 15213, USA.

出版信息

Crit Care Clin. 2020 Apr;36(2):357-377. doi: 10.1016/j.ccc.2019.12.006. Epub 2020 Feb 6.

DOI:10.1016/j.ccc.2019.12.006
PMID:32172818
Abstract

Hemostatic abnormalities are common among critically ill patients and are associated with a high risk of bleeding. The abnormalities range from isolated thrombocytopenia or prolongation of global coagulation assays to complex disease states, such as thrombotic microangiopathic syndromes, and can be associated with a wide range of conditions, including trauma, surgery, acute disease processes, cardiopulmonary bypass, and exposure to drugs and blood products. Prompt identification of underlying causes is important because treatment strategies vary. Moreover, prompt initiation of both supportive and specific treatments is vital to decrease the morbidity and mortality in the intensive care unit.

摘要

严重疾病患者中常出现止血功能异常,且这些异常与高出血风险相关。这些异常的范围很广,从孤立性血小板减少症或全凝血检测时间延长,到血栓性微血管病综合征等复杂疾病状态,可能与包括创伤、手术、急性疾病过程、体外循环和接触药物和血液制品在内的广泛情况相关。及时确定潜在病因很重要,因为治疗策略有所不同。此外,及时启动支持治疗和特异性治疗对降低重症监护病房的发病率和死亡率至关重要。

相似文献

1
Thrombotic Thrombocytopenic Purpura, Heparin-Induced Thrombocytopenia, and Disseminated Intravascular Coagulation.血栓性血小板减少性紫癜、肝素诱导的血小板减少症和弥散性血管内凝血。
Crit Care Clin. 2020 Apr;36(2):357-377. doi: 10.1016/j.ccc.2019.12.006. Epub 2020 Feb 6.
2
Thrombocytopenic disorders in critically ill patients.危重症患者的血小板减少症
Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):347-51. doi: 10.1164/ajrccm.162.2.ncc3-00.
3
Thrombotic thrombocytopenic purpura and heparin-induced thrombocytopenia: two unique causes of life-threatening thrombocytopenia.血栓性血小板减少性紫癜和肝素诱导的血小板减少症:危及生命的血小板减少症的两种独特病因。
Clin Lab Med. 2009 Jun;29(2):321-38. doi: 10.1016/j.cll.2009.03.003.
4
[Thrombocytopenia in the intensive care unit : Diagnosis, differential diagnosis, and treatment].[重症监护病房中的血小板减少症:诊断、鉴别诊断及治疗]
Med Klin Intensivmed Notfmed. 2016 Jun;111(5):425-33. doi: 10.1007/s00063-016-0174-8. Epub 2016 Jun 2.
5
[Kidney diseases associated with hemolytic uremic syndrome,thrombotic thrombocytopenic purpura and disseminated intravascular coagulation].与溶血性尿毒症综合征、血栓性血小板减少性紫癜及弥散性血管内凝血相关的肾脏疾病
Nihon Naika Gakkai Zasshi. 1992 Jan 10;81(1):73-6.
6
[Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].[转移性前列腺癌合并慢性弥散性血管内凝血致急性肾衰竭,酷似血栓性血小板减少性紫癜和溶血尿毒综合征:病例相关的发病机制、鉴别诊断及治疗]
Magy Onkol. 2010 Dec;54(4):351-7. doi: 10.1556/MOnkol.54.2010.4.9.
7
Co-existence of heparin-induced thrombocytopenia and thrombotic thrombocytopenic purpura in a postoperative cardiac surgery patient.一名心脏手术后患者同时存在肝素诱导的血小板减少症和血栓性血小板减少性紫癜。
Am J Hematol. 2005 Dec;80(4):288-91. doi: 10.1002/ajh.20436.
8
Bleeding and thrombotic complications in critically ill patients with cancer.癌症危重症患者的出血和血栓形成并发症
Crit Care Clin. 2001 Jul;17(3):599-622. doi: 10.1016/s0749-0704(05)70200-1.
9
Heparin-induced thrombocytopenia in critically ill patients.危重症患者的肝素诱导血小板减少症。
Semin Thromb Hemost. 2015 Feb;41(1):49-60. doi: 10.1055/s-0034-1398381. Epub 2015 Jan 15.
10
Acute thrombocytopenia and thrombosis. Heparin-induced thrombocytopenia and thrombotic thrombocytopenic purpura.急性血小板减少症与血栓形成。肝素诱导的血小板减少症和血栓性血小板减少性紫癜。
Ann N Y Acad Sci. 1987;509:205-21. doi: 10.1111/j.1749-6632.1987.tb30996.x.

引用本文的文献

1
Hypertensive Emergency as the Initial Presentation of Acquired Thrombotic Thrombocytopenic Purpura: A Case Report.高血压急症作为获得性血栓性血小板减少性紫癜的首发表现:一例报告
Cureus. 2021 Dec 5;13(12):e20176. doi: 10.7759/cureus.20176. eCollection 2021 Dec.
2
Case Report: Acute Splenic Artery Thrombosis in a COVID 19, Postpartum Patient.病例报告:一名新冠病毒感染后的产后患者发生急性脾动脉血栓形成
Front Med (Lausanne). 2021 Nov 5;8:698627. doi: 10.3389/fmed.2021.698627. eCollection 2021.
3
Recurrence of Thrombotic Thrombocytopenic Purpura after mRNA-1273 COVID-19 Vaccine Administered Shortly after COVID-19.
新冠病毒感染后不久接种mRNA-1273新冠疫苗后血栓性血小板减少性紫癜复发
Case Rep Hematol. 2021 Sep 13;2021:4130138. doi: 10.1155/2021/4130138. eCollection 2021.
4
Thrombotic complications of COVID-19.COVID-19 的血栓并发症。
Am J Emerg Med. 2021 Jan;39:213-218. doi: 10.1016/j.ajem.2020.09.065. Epub 2020 Oct 1.
5
Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients.COVID-19 危重症患者 D-二聚体、弥漫性血管内凝血和抗凝治疗预后效用的系统评价。
Med Intensiva (Engl Ed). 2021 Jan-Feb;45(1):42-55. doi: 10.1016/j.medin.2020.06.006. Epub 2020 Jun 17.